Literature DB >> 15235035

Keratin 8 Y54H and G62C mutations are not associated with liver disease.

J Halangk, T Berg, G Puhl, T Mueller, R Nickel, A Kage, O Landt, W Luck, B Wiedenmann, P Neuhaus, H Witt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15235035      PMCID： PMC1735848          DOI： 10.1136/jmg.2003.011650

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  3 in total

1.  Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer.

Authors:  Matthias Treiber; Hans-Ulrich Schulz; Olfert Landt; Joost P H Drenth; Carlo Castellani; Francisco X Real; Nejat Akar; Rudolf W Ammann; Mario Bargetzi; Eesh Bhatia; Andrew Glenn Demaine; Cinzia Battagia; Andrew Kingsnorth; Derek O'Reilly; Kaspar Truninger; Monika Koudova; Julius Spicak; Milos Cerny; Hans-Jürgen Menzel; Pedro Moral; Pier Franco Pignatti; Maria Grazia Romanelli; Olga Rickards; Gian Franco De Stefano; Narcis Octavian Zarnescu; Gourdas Choudhuri; Sadiq S Sikora; Jan B M J Jansen; Frank Ulrich Weiss; Matthias Pietschmann; Niels Teich; Thomas M Gress; Johann Ockenga; Hartmut Schmidt; Andreas Kage; Juliane Halangk; Jonas Rosendahl; David Alexander Groneberg; Renate Nickel; Heiko Witt
Journal:  J Mol Med (Berl)       Date:  2006-10-13       Impact factor: 4.599

2.  Keratin 8 variants are associated with cryptogenic hepatitis.

Authors:  Mario Zierden; Arndt-Hendrik Penner; Manuel Montesinos-Rongen; Maren Weferling; Uta Drebber; Judith Stift; Jochen W U Fries; Margarete Odenthal; Stephan Rosenkranz; Hans-Peter Dienes
Journal:  Virchows Arch       Date:  2012-03-15       Impact factor: 4.064

3.  Keratin 8 variants are infrequent in patients with alcohol-related liver cirrhosis and do not associate with development of hepatocellular carcinoma.

Authors:  Valentyn Usachov; Pierre Nahon; Mariia Lunova; Marianne Ziol; Pierre Rufat; Angela Sutton; Michel Beaugrand; Pavel Strnad
Journal:  BMC Gastroenterol       Date:  2012-10-18       Impact factor: 3.067
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.